TCRCure Biopharma Ltd was founded in August 2016 by a team of immunologists and cell engineers from both the USA and China. TCRCure is headquartered in Beijing, China. Over the course of two years, TCRCure has established R&D sites in Los Angeles, California and Research Triangle Park, North Carolina, as well as a translational medicine center in Chongqing, China. In 2017, TCRCure successfully closed Series A funding. This investment was led by multiple professional healthcare venture capital firms, including Share Capital and ETP Biomedical Venture Capital. To date, TCRCure possesses streamlined biotechnology development including vector and cell manufacturing, which enables clinical translation intended for full-fledged immunotherapy services……
Los Angeles California
Address: 5370 Alhambra Ave Ste F, Los Angeles, CA 90032, USA
Durham North Carolina
Address: 701 West Main St. Suite 200, Durham 27701 USA
Thank you for coming to TCRCure, if you have the intention of cooperation, please leave us a message or use the following ways to contact us, and to provide you with the most sincere professional services, thank you.